Expertise in
1
conditions

Sergey E. Borisov

Stromynka Str. 10, 
Moscow, MOW, RU 
Expertise in
1
conditions
Stromynka Str. 10, 
Moscow, MOW, RU 

Overview

Sergey Borisov practices practicing medicine in Moscow, Russian Federation.

Mr. Borisov is highly rated in 1 condition, according to our data. His clinical expertise encompasses Pulmonary Tuberculosis, Sarcoidosis, HIV/AIDS, and Severe Acute Respiratory Syndrome (SARS).

He is actively involved in clinical research, co-authoring 26 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Stromynka Str. 10, Moscow, MOW 107014, Russian Federation

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Open-Label, Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of a 4-month Treatment of Bedaquiline Plus Pretomanid Plus Moxifloxacin Plus Pyrazinamide (BPaMZ) Compared to a 6-month Treatment of HRZE/HR (Control) in Adult Participants With Drug-Sensitive Smear-Positive Pulmonary Tuberculosis (DS-TB) and a 6-month Treatment of BPaMZ in Adult Participants With Drug Resistant, Smear-Positive Pulmonary Tuberculosis (DR-TB)
An Open-Label, Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of a 4-month Treatment of Bedaquiline Plus Pretomanid Plus Moxifloxacin Plus Pyrazinamide (BPaMZ) Compared to a 6-month Treatment of HRZE/HR (Control) in Adult Participants With Drug-Sensitive Smear-Positive Pulmonary Tuberculosis (DS-TB) and a 6-month Treatment of BPaMZ in Adult Participants With Drug Resistant, Smear-Positive Pulmonary Tuberculosis (DR-TB)
Enrollment Status: Completed
Publish Date: August 27, 2026
Intervention Type: Drug
Study Drugs: Pretomanid, Bedaquiline, Moxifloxacin, Pyrazinamide, HRZE, HR
Study Phase: Phase 2/Phase 3
A Phase 3 Partially-blinded, Randomized Trial Assessing the Safety and Efficacy of Various Doses and Treatment Durations of Linezolid Plus Bedaquiline and Pretomanid in Participants With Pulmonary Infection of Either Extensively Drug-resistant Tuberculosis (XDR-TB), Pre-XDR-TB or Treatment Intolerant or Non-responsive Multi-drug Resistant Tuberculosis (MDR-TB)
A Phase 3 Partially-blinded, Randomized Trial Assessing the Safety and Efficacy of Various Doses and Treatment Durations of Linezolid Plus Bedaquiline and Pretomanid in Participants With Pulmonary Infection of Either Extensively Drug-resistant Tuberculosis (XDR-TB), Pre-XDR-TB or Treatment Intolerant or Non-responsive Multi-drug Resistant Tuberculosis (MDR-TB)
Enrollment Status: Completed
Publish Date: June 29, 2023
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

26 Total Publications

Clinical standards for the management of adverse effects during treatment for TB.
Clinical standards for the management of adverse effects during treatment for TB.
Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: June 24, 2023

Frequently Asked Questions about Sergey E. Borisov

Is Sergey E. Borisov a top-rated expert for Pulmonary Tuberculosis?

MediFind is an objective health platform that identifies experts based on real-world data. Sergey E. Borisov is classified as an Advanced expert for Pulmonary Tuberculosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sergey E. Borisov participate in research or clinical trials?

Yes. Sergey E. Borisov has published 26 articles and abstracts on conditions like Pulmonary Tuberculosis. You can view a list of Sergey E. Borisov's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Borisov's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile